Susquehanna International Group, LLP Zymeworks Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.43 $38,130 - $60,926	-8,200 Reduced 8.12%	92,800 $571,000
Q2 2022 Aug 15, 2022	BUY	$4.82 - $7.7 $348,968 - $557,480	72,400 Added 253.15%	101,000 $535,000
Q1 2022 May 16, 2022	SELL	$6.0 - $16.98 $27,600 - $78,108	-4,600 Reduced 13.86%	28,600 $187,000
Q4 2021 Feb 14, 2022	SELL	$15.19 - $29.33 $776,209 - $1.5 Million	-51,100 Reduced 60.62%	33,200 $544,000
Q3 2021 Nov 15, 2021	SELL	$27.35 - $37.28 $522,385 - $712,048	-19,100 Reduced 18.47%	84,300 $2.45 Million
Q2 2021 Aug 11, 2021	BUY	$26.5 - $38.23 $1.28 Million - $1.85 Million	48,300 Added 87.66%	103,400 $3.59 Million
Q1 2021 May 17, 2021	SELL	$29.83 - $56.81 $1.3 Million - $2.48 Million	-43,600 Reduced 44.17%	55,100 $1.74 Million
Q4 2020 Feb 16, 2021	SELL	$39.12 - $54.99 $457,703 - $643,383	-11,700 Reduced 10.6%	98,700 $4.67 Million
Q3 2020 Nov 16, 2020	BUY	$29.21 - $46.58 $1.66 Million - $2.65 Million	56,900 Added 106.36%	110,400 $5.14 Million
Q2 2020 Aug 14, 2020	BUY	$33.67 - $40.0 $279,461 - $332,000	8,300 Added 18.36%	53,500 $1.93 Million
Q1 2020 May 15, 2020	SELL	$24.28 - $49.8 $619,140 - $1.27 Million	-25,500 Reduced 36.07%	45,200 $1.6 Million
Q4 2019 Feb 14, 2020	BUY	$24.84 - $45.46 $1.15 Million - $2.11 Million	46,400 Added 190.95%	70,700 $3.21 Million
Q3 2019 Nov 14, 2019	SELL	$22.78 - $29.08 $494,326 - $631,036	-21,700 Reduced 47.17%	24,300 $603,000
Q2 2019 Aug 14, 2019	BUY	$15.0 - $22.49 $252,000 - $377,832	16,800 Added 57.53%	46,000 $1.01 Million
Q1 2019 May 15, 2019	BUY	$14.02 - $16.74 $147,210 - $175,769	10,500 Added 56.15%	29,200 $472,000
Q4 2018 Feb 14, 2019	BUY	$10.95 - $15.44 $204,765 - $288,728	18,700 New	18,700 $275,000

Others Institutions Holding ZYME

# of Institutions

Shares Held

296K

Call Options Held

Put Options Held

Strategic Wealth Advisors Group, LLC Sacramento, CA

296K
Shares

$4.19 Million
0.08% of portfolio

View Full List

About Zymeworks Inc.

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $872M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

More about ZYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account